
LipoAvail® is an advanced liposomal technology that encapsulates silymarin within a double molecular layer of lipids, enhancing the bioavailability of silymarin.
Compared with regular silymarin, the bioavailability of LipoAvail® silymarin is elevated by 50 times.

LIVER HEALTH SUPPORT

ANTIOXIDANT SUPPORT

ANTI-INFLAMMATORY PROPERTIES

HEART AND BLOOD VESSEL SUPPORT

IMMUNE SUPPORT
-02.png)



Silymarin
is a natural flavonoid compound derived from milk thistle seeds that contains silybin as its primary active ingredient. It acts as a natural protector of the liver, helping to shield it from toxins.

LIVER HEALTH SUPPORT

ANTIOXIDANT SUPPORT

ANTI-INFLAMMATORY PROPERTIES

HEART AND BLOOD VESSEL SUPPORT

IMMUNE SUPPORT

-06.png)
After 15 days of administering various samples alongside liver-damaging agents, researchers measured serum AST and ALT* levels in mice to detect the effectiveness of liver injury protection. LipoAvail® Liposomal Silymarin showed the most substantial hepatoprotective effect, reducing ALT by 41.72% and AST by 44.3% compared to the regular silymarin group—an overall improvement of approximately 40% in liver protection.
Histological analysis supported these findings: while silymarin alone reduced liver damage markers such as interstitial space and vacuolization, the liposomal formulation provided significantly greater protection, indicating LipoAvail™ Liposomal Silymarin as the most effective intervention among the market-available silymarin products and regular ones.
*AST (aspartate aminotransferase) and ALT (alanine aminotransferase) are common biomarkers used to assess liver health. When liver damage occurs, these enzymes are released from hepatocytes (liver cells) into the bloodstream, leading to elevated serum levels. An abnormal rise in AST and ALT is a typical indication of liver injury or dysfunction.

Relative bioavailability is the ratio of AUC0-t for LipoAvail® silymarin and regular silymarin after oral administration, indicating the effect of silymarin absorption elevated by LipoAvail™ liposomal technology.

We deliver authentic liposomal silymarin under LipoAvail® 360° multi-dimensional quality evaluation system.
Silymarin content of 35% and 50%,
Regular spherical morphology,
Excellent particle size distribution with an average diameter of 28 nm.

Cold water dispersibility
Regular silymarin (as shown on the left) is insoluble in water, with obvious stratification.
LipoAvail™ silymarin (as shown on the right) can be evenly dispersed in water as an emulsion.

Powder

Tablets

Hard capsules

Softgel capsules





Reference available upon request.
The content on this page is for business use only and is not intended for end consumers.
| These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. |
Information on this site is provided for informational purposes only. It is not meant to substitute for medical advice from your physician or other medical professional. You should not use the information contained herein to diagnose or treat a health problem or disease or prescribe any medication. Carefully read all product documentation. If you have or suspect that you have a medical problem, promptly contact your regular healthcare provider.
LipoAvail® is a registered trademark of EffePharm Ltd.